Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Elvira, Agazio"'
Publikováno v:
BMC Endocrine Disorders, Vol 22, Iss 1, Pp 1-8 (2022)
Abstract Background In adult population, Growth Hormone Deficiency (GHD) is a complex clinical condition with heterogeneity of causes and duration. Growth Hormone (GH) replacement therapy has beneficial effects entailing a chronic and expensive use.
Externí odkaz:
https://doaj.org/article/1262167775e4460d919ae340b74780ba
Autor:
Monica Monaco, Marco Floridia, Marina Giuliano, Luigi Palmieri, Cinzia Lo Noce, Annalisa Pantosti, Anna Teresa Palamara, Silvio Brusaferro, Graziano Onder, The Italian National Institute of Health COVID-19 Mortality Group, Elvira Agazio, Pierfrancesco Barbariol, Antonino Bella, Eva Benelli, Luigi Bertinato, Matilde Bocci, Stefano Boros, Marco Bressi, Giovanni Calcagnini, Federica Censi, Alessandra Ciervo, Elisa Colaizzo, Cecilia Damiano, Martina Del Manso, Corrado Di Benedetto, Chiara Donfrancesco, Massimo Fabiani, Francesco Facchiano, Fabio Galati, Tiziana Grisetti, Cecilia Guastadisegni, Pietro Maiozzi, Valerio Manno, Margherita Martini, Alberto Mateo Urdiales, Eugenio Mattei, Claudia Meduri, Paola Meli, Giada Minelli, Daniele Petrone, Patrizio Pezzotti, Flavia Pricci, Ornella Punzo, Flavia Riccardo, Chiara Sacco, Paolo Salerno, Debora Serra, Matteo Spuri, Marco Tallon, Manuela Tamburo De Bella, Dorina Tiple, Brigid Unim, Luana Vaianella, Maria Fenicia Vescio, Liliana Elena Weimer
Publikováno v:
Frontiers in Medicine, Vol 9 (2022)
IntroductionIn hospitalized patients with COVID-19, bloodstream infections (BSI) are associated with high mortality and high antibiotic resistance rates. The aim of this study was to describe BSI etiology, antimicrobial resistance profile and risk fa
Externí odkaz:
https://doaj.org/article/1ec41fa91dbb4f3cbe29001d0777ef86
Autor:
Gianluca Tornese, Flavia Pricci, Maria Chiara Pellegrin, Marika Villa, Daniela Rotondi, Elvira Agazio, Egidio Barbi
Publikováno v:
Italian Journal of Pediatrics, Vol 45, Iss 1, Pp 1-5 (2019)
Abstract Recombinant human growth hormone (rhGH) is an approved and effective treatment for short children born small for gestational age (SGA). Prevalence of children eligible for treatment as SGA is reported to be 1:1800. The latest data from the N
Externí odkaz:
https://doaj.org/article/f9dbc813e2344980bbc63f82b464def5
Autor:
Floridia, Marco, Giuliano, Marina, Monaco, Monica, Palmieri, Luigi, Lo Noce, Cinzia, Palamara, Anna Teresa, Pantosti, Annalisa, Brusaferro, Silvio, Onder, Graziano, The Italian National Institute of Health Covid-Mortality Group: Luigi Palmieri, Elvira, Agazio, Pierfrancesco, Barbariol, Antonino, Bella, Eva, Benelli, Luigi, Bertinato, Matilde, Bocci, Stefano, Boros, Marco, Bressi, Giovanni, Calcagnini, Marco, Canevelli, Federica, Censi, Alessandra, Ciervo, Elisa, Colaizzo, Roberto Da Cas, Martina Del Manso, Corrado Di Benedetto, Chiara, Donfrancesco, Massimo, Fabiani, Francesco, Facchiano, Marco, Floridia, Fabio, Galati, Marina, Giuliano, Tiziana, Grisetti, Cecilia, Guastadisegni, Ilaria, Lega, Cinzia Lo Noce, Pietro, Maiozzi, Valerio, Manno, Margherita, Martini, Marco, Massari, Alberto Mateo Urdiales, Eugenio, Mattei, Claudia, Meduri, Paola, Meli, Francesca Menniti Ippolito, Giada, Minelli, Graziano, Onder, Daniele, Petrone, Patrizio, Pezzotti, Flavia, Pricci, Ornella, Punzo, Federica, Quarata, Raparelli, Valeria, Flavia, Riccardo, Simone, Rocchetto, Chiara, Sacco, Paolo, Salerno, Giulia, Sarti, Debora, Serra, Stefania Spila Alegiani, Matteo, Spuri, Marco, Tallon, Manuela Tamburo De Bella, Dorina, Tiple, Marco Toccaceli Blasi, Federica, Trentin, Brigid, Unim, Luana, Vaianella, Nicola, Vanacore, Maria Fenicia Vescio, Emanuele Rocco Villani, Liliana Elena Weimer, Silvio, Brusaferro
Publikováno v:
Antimicrobial Resistance & Infection Control. 11
Background Patients hospitalised for COVID-19 may present with or acquire bacterial or fungal infections that can affect the course of the disease. The aim of this study was to describe the microbiological characteristics of laboratory-confirmed infe
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::30db03fc6f78360e2c7777dfd02cc5c2
https://doi.org/10.1186/s13756-022-01113-y
https://doi.org/10.1186/s13756-022-01113-y
Autor:
Daniela Rotondi, Paolo Roazzi, Elvira Agazio, Marika Villa, P Panei, Flavia Pricci, Fabio Maccari
Publikováno v:
Journal of Endocrinological Investigation
Background In Italy, the utilization and the reimbursement of Growth Hormone (rGH) therapy by the National Health System (Servizio Sanitario Nazionale) are regulated by the “Note #39” included in the “Notes for the use of drugs” by the Italia
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6f0363999742e6fa5176f5ccfd8d6ab5
https://doi.org/10.1007/s40618-018-0980-3
https://doi.org/10.1007/s40618-018-0980-3
Autor:
Daniela Rotondi, Elvira Agazio, Maria Chiara Pellegrin, Marika Villa, Flavia Pricci, Egidio Barbi, Gianluca Tornese
Publikováno v:
Italian Journal of Pediatrics
Italian Journal of Pediatrics, Vol 45, Iss 1, Pp 1-5 (2019)
Italian Journal of Pediatrics, Vol 45, Iss 1, Pp 1-5 (2019)
Recombinant human growth hormone (rhGH) is an approved and effective treatment for short children born small for gestational age (SGA). Prevalence of children eligible for treatment as SGA is reported to be 1:1800. The latest data from the National R
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::fec8292870f4ac4c8fe84f8054a89c4c
https://ijponline.biomedcentral.com/articles/10.1186/s13052-019-0715-x
https://ijponline.biomedcentral.com/articles/10.1186/s13052-019-0715-x
